Stockscreener 앱 받기
6.51
12.62%
-0.94
시간 외 거래:
6.36
-0.15
-2.30%
Turn Therapeutics Inc 주식(TTRX)의 최신 뉴스
Will Apogee Therapeutics Inc. stock split attract more investorsStock Surge & Safe Swing Trade Setup Alerts - newser.com
Can trapped investors hope for a rebound in Unicycive Therapeutics Inc.Quarterly Earnings Summary & Intraday High Probability Setup Alerts - newser.com
Turn Therapeutics files prospectus relates to offer, sale of up to 7 mln shares - MarketScreener
Stock skyrockets after Turn goes public - BioWorld MedTech
Dow Dips Over 250 Points; Delta Air Lines Posts Upbeat Earnings - Benzinga
Turn Therapeutics (TTRX) Skyrockets After Nasdaq Debut – Biotech Breakthrough or Hype? - ts2.tech
Strength Seen in Septerna, Inc. (SEPN): Can Its 7.0% Jump Turn into More Strength? - Yahoo Finance
US Stocks Mixed; Nasdaq Falls Over 50 Points - Benzinga
Pre-Market Titans: TTRX, BJDX & UPC Set The Pace - RTTNews
Stock Market Today: S&P 500, Nasdaq Futures Slip As Fed Minutes Signal Tariff-Related Uncertainty—PepsiCo, Delta, Levi Strauss In Focus (UPDATED) - Benzinga
Why Richardson Electronics Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket - Benzinga
Why Is Turn Therapeutics Stock Soaring Over 370% Premarket Today? - MSN
Turn Therapeutics Shares Skyrocket 134% After Hours Following Nasdaq Debut - Benzinga
After-Hours Surge: Turn Therapeutics Rockets 134% Post-Close On Nasdaq Debut; Biotech Stocks Rally - Nasdaq
Turn Therapeutics Inc.Common Stock (Nasdaq:TTRX) Stock Quote - FinancialContent
Turn Therapeutics to Commence Trading Today on Nasdaq - Yahoo Finance
Turn Therapeutics (Direct Listing) Plans $0.00 IPO for Week of October 13th (TTRX) - Defense World
Sarepta Therapeutics Stock Skyrockets After FDA U-Turn – Gene Therapy Drama Explained! - ts2.tech
Turn Therapeutics Inc. Announces Board and Committee Appointments, Effective September 30, 2025 - MarketScreener
Crystalys Therapeutics Launches with $205M Series A Financing to Transform the Treatment of Gout - PR Newswire
Turn Therapeutics Announces Expected First Day of Trading on NASDAQ Global Market - Business Wire
Can Zevra Therapeutics (ZVRA) Turn Clinical Momentum Into Sustainable Competitive Advantage? - Yahoo Finance
This Sarepta Therapeutics Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday - Benzinga
Strength Seen in Amicus Therapeutics (FOLD): Can Its 6.4% Jump Turn into More Strength? - Yahoo Finance
Turn Therapeutics to Host Open Investor Session in Connection with Expected Public Listing on Nasdaq - Business Wire
Strength Seen in Silicon Motion (SIMO): Can Its 6.4% Jump Turn into More Strength? - Yahoo Finance
Strength Seen in Travere (TVTX): Can Its 26.2% Jump Turn into More Strength? - Yahoo Finance
After dropping IPO plans, Odyssey Therapeutics turns to VC for capital - The Business Journals
impact.com Announces Sustained Growth in Q2 2025 as Consumers Turn to Authentic Connections with Trusted Communities and Brands - Yahoo Finance
TTRX IPO NewsWound and dermatology-focused Turn Therapeutics files for a direct listing on the Nasdaq - renaissancecapital.com
Superbug Survivor and Turn Therapeutics CEO Launches Podcast to Spotlight Hidden Scientific Breakthroughs - Business Wire
Glenmark Pharma will turn cash positive with AbbVie's licensing deal: S&P - The Economic Times
Turn Therapeutics Begins Clinical Trial of First Topical IL-36/IL-31 Inhibitor for Eczema - Business Wire
Junior Patriots™ Begins Initiative to Turn 1,000 Young Americans Into #1 Best Selling Authors in 2025 - Yahoo Finance
This Sarepta Therapeutics Analyst Turns Bearish; Here Are Top 5 Downgrades For Wednesday - Benzinga
InMed Pharmaceuticals’ Surprising Stock Rise: A Profitable Turn? - timothysykes.com
When Will Amicus Therapeutics, Inc. (NASDAQ:FOLD) Turn A Profit? - simplywall.st
China is catching up to the U.S. in pharmaceuticals, but it’s not too late to turn that around - Fast Company
Vertical Aerospace Ltd. (NYSE:EVTL) Is About To Turn The Corner - Yahoo Finance
Allogene Therapeutics: Still Looking Shaky, But Looking To Turn The Corner (Rating Upgrade) - Seeking Alpha
With Trials In Motion, Cash To 2027, Can Kyverna's Next Data Drop Turn The Stock Around? - Benzinga
Turn Therapeutics Announces Vaccine Breakthrough: Validates 100% VSV Recovery from Petrolatum Carrier at 24 and 72 Hours - Business Wire
Strength Seen in Recursion Pharmaceuticals (RXRX): Can Its 27.7% Jump Turn into More Strength? - Yahoo Finance
Spevigo so-so, innovator takes another Turn at IL-36 in eczema - BioWorld MedTech
When Will Rakovina Therapeutics Inc. (CVE:RKV) Turn A Profit? - Yahoo Finance
Turn Therapeutics Launches Final Crowdfund Round Ahead of Eczema Trial Enrollment, Engages Clear Street to Explore Public Markets - Business Wire
Turn Biotechnologies Acquires ARMMs Vesicular Technology to Increase Access to Tissue Targets for Its Epigenetic Reprogramming Therapies - PR Newswire
Autolus Therapeutics Stock: Will The Tide Turn? - StocksToTrade
Cell therapy biotech Century Therapeutics axes cancer trial, turns to autoimmune - fiercebiotech.com
Strength Seen in TG Therapeutics (TGTX): Can Its 10.2% Jump Turn into More Strength? - Yahoo Finance
Biotech startup looks to turn founders' experience, $20 million against epilepsy - The Business Journals
Can Contineum's Upcoming Catalysts Turn The Tide In The Coming Months? - RTTNews
TransCode Therapeutics: A Turning Point for RNAZ? - StocksToTrade
You Can’t Buy Us: Biotechs Turn to Courts to Fight Off Potential Buyers - BioSpace
Verve Therapeutics to Participate in the Guggenheim Securities SMID Cap Biotech Conference - The Manila Times
Viking Therapeutics: The Turning Point Is Not Here Yet - Seeking Alpha
Stock market today: Dow pops, Nasdaq slips as focus turns to CPI inflation report - Yahoo Finance
3 Stocks That Could Turn $1,000 into $5,000 by 2030 - Yahoo Finance
Turn Therapeutics Secures $75 Million Investment Commitment Tied to Public Listing - Yahoo Finance
Editor’s pick: Switch Therapeutics - Nature
Astellas Gene Therapies to turn out the lights at South San Francisco production plant - Fierce Pharma
When Will Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Turn A Profit? - Yahoo Finance
Could This New Drug Turn Back the Clock on Multiple Sclerosis? - UC San Francisco
3 Penny Stocks Poised to Turn Pocket Change Into a Small Fortune by 2028 - Yahoo Finance
Ugly shoes are here to stay: Ugg, Crocs thriving as consumers turn to comfort - Yahoo Finance
3 Explosive Stocks to Turn $10K into $1M by 2030 - Yahoo Finance
3 Penny Stocks to Turn $999 Into $1 Million: January 2024 - InvestorPlace
Spero CEO to step down; new CEO to turn focus toward lung disease antibiotic - The Business Journals
When Will Esperion Therapeutics, Inc. (NASDAQ:ESPR) Turn A Profit? - Yahoo Finance
3 Biotech Stocks That Could Turn $1,000 into $10,000 by 2024 - Yahoo Finance
Layoffs and Shutdowns Hit Biotech Industry in U-Turn - The Wall Street Journal
Areteia gets $350M to turn failed ALS drug into a therapy for severe asthma - MedCity News
MD Anderson and Turning Point Therapeutics announce strategic alliance to advance precision cancer therapies - MD Anderson Cancer Center
Bristol Myers boosts cancer drug portfolio with $4.1 billion Turning Point deal - Reuters
When Will Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Turn A Profit? - simplywall.st
Astellas-backed Turn Bio is Advancing Epigenetics for Long, Healthy Life Span - BioSpace
1.11%
자본화:
|
볼륨(24시간):